Form D · Other Health Care
Gene Sciences, Inc.
San Diego, CA · CIK 0001690532
Offering snapshot reported Nov 22, 2016 · SEC filing
- Reported sold
- $8M Offering amount: $12M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 10, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2016 | Initial | $8,000,045 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-275027
Includes $45.00 of Common Stock sold separately from Series A Preferred Stock to one purchaser included below.
Source: Form D, filed Nov 22, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James C. Blair | Director, Executive |
| James T. Demetriades | Director |
| Peter Dervan | Director |
| Lynne Rollins | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
12481 High Bluff Drive Suite 150
San Diego, CA, 92130
San Diego, CA, 92130